Document Detail

The levels of lipids, lipoproteins and apolipoproteins in healthy people in the central region of the Black Sea.
MedLine Citation:
PMID:  10611907     Owner:  NLM     Status:  MEDLINE    
Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age--coronary artery disease (CAD). They vary from country to country, from area to area within a country, depending on genetic, environmental, dietary and many other factors. Our aim was to determine the levels of lipids, lipoproteins and apolipoproteins in healthy people in the central Black Sea region of Turkey. Subjects included 1348 volunteers (682 women, 666 men) referred to the Medical Faculty hospital from the study area. The population consisted of healthy people or those whose disease was not affecting the metabolism of lipids. Cholesterol, triglyceride and HDL-cholesterol levels in the obtained serum samples were measured spectrophotometrically, while apolipoprotein A-I, apolipoprotein B, apolipoprotein E and lipoprotein(a) levels were measured nephelometrically. The levels of lipid parameters were as follows: total cholesterol for men was 4.22 +/- 1.00 mmol/l (mean arithmetic +/- SD), triglyceride 1.20 mmol/l (0.30-4.44) [geometric mean (range)], HDL-cholesterol 0.88 +/- 0.22 mmol/l, LDL-cholesterol 2.69 +/- 0.85 mmol/l, apolipoprotein A-I 1.26 +/- 0.22 mmol/l apolipoprotein B 1.12 +/- 0.32 mmol/l, apolipoprotein E 0.037 +/- 0.012 mmol/l and lipoprotein(a) 0.25 g/l (0.03-2.75); total cholesterol for women was 4.53 +/- 1.00 mmol/l, triglyceride 1.05 mmol/l (0.28-4.50), HDL-cholesterol 1.08 +/- 0.26 mmol/l, LDL-cholesterol 2.87 +/- 0.88 mmol/l, apolipoprotein A-I 1.45 +/- 0.25 mmol/l, apolipoprotein B 1.11 +/- 0.31 mmol/l, apolipoprotein E 0.039 +/- 0.011 mmol/l and lipoprotein(a) 0.22 g/l (0.03 2.16). In conclusion, our study in four different regions in Turkey reflected that the people living in the central Black Sea region are less vulnerable to the risk of CAD, although at a relatively higher risk compared to some other countries.
B Adam; C Talu; A Bedir; M Alvur; O Sağkan
Related Documents :
1993347 - Heterozygous hypobetalipoproteinemia with fasting chylomicronemia.
9627377 - Short-term administration of tall oil phytosterols improves plasma lipid profiles in su...
19329177 - Reduction in c-reactive protein and ldl cholesterol and cardiovascular event rates afte...
7332607 - Atherogenesis in experimental uremia.
9732937 - Gluten-free diet induces regression of t-cell activation in the rectal mucosa of patien...
824027 - Effects of protein malnutrition during development on protein synthesis in brain and pe...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Japanese heart journal     Volume:  40     ISSN:  0021-4868     ISO Abbreviation:  Jpn Heart J     Publication Date:  1999 Jul 
Date Detail:
Created Date:  2000-01-05     Completed Date:  2000-01-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401175     Medline TA:  Jpn Heart J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  427-34     Citation Subset:  IM    
Department of Biochemistry, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apolipoproteins / blood*
Apolipoproteins A / blood
Apolipoproteins B / blood
Apolipoproteins E / blood
Blood Pressure / physiology
Lipids / blood*
Lipoproteins / blood*
Middle Aged
Reg. No./Substance:
0/Apolipoproteins; 0/Apolipoproteins A; 0/Apolipoproteins B; 0/Apolipoproteins E; 0/Lipids; 0/Lipoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of cardiac function in myocardial infarction patients by ECG 99mTc-MIBI gated SPECT using...
Next Document:  Familial hypercholesterolemia in Utah kindred with novel 2412-6 Ins G mutations in exon 17 of the LD...